International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): Clinical implications and treatment practice suggestions

This publication has 80 references indexed in Scilit:

• Psychotropic Medicines and Aggressive Behavior Part II: Antipsychotics and Mood Stabilizers
  Child and Adolescent Psychopharmacology News, 2003
• Double-Blind, Placebo-Controlled Study of Risperidone for the Treatment of Disruptive Behaviors in Children With Subaverage Intelligence
  American Journal of Psychiatry, 2002
• Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials
  European Neuropsychopharmacology, 2001
• The Child and Adolescent Psychiatric Assessment (CAPA)
  Journal of the American Academy of Child & Adolescent Psychiatry, 2000
• Methyiphenidate vs. amphetamine: Comparative review
  Journal of Attention Disorders, 2000
• Comorbidity
  Journal of Child Psychology and Psychiatry, 1999
• The Nisonger CBRF: A child behavior rating form for children with developmental disabilities
  Research in Developmental Disabilities, 1996
• A Double-blind Placebo Controlled Study of Desipramine in the Treatment of ADD: II. Serum Drug Levels and Cardiovascular Findings
  Journal of the American Academy of Child & Adolescent Psychiatry, 1989
• Cognitive training in academically deficient ADDH boys receiving stimulant medication
  Journal of Abnormal Child Psychology, 1988
• A Four-Year Follow-up of Hyperactive Boys with and without Conduct Disorder
  The British Journal of Psychiatry, 1983